deltatrials
Terminated PHASE2 INTERVENTIONAL 12-arm NCT04115098

Individualizing Anti-Inflammatory Medications for Adults With Axial Spondyloarthritis: A Series of N-of 1 Trials

Sponsor: National Center for Advancing Translational Sciences (NCATS)

Conditions Axial Spondyloarthritis
Interventions Celecoxib Meloxicam Naproxen
Updated 12 times since 2019 Last updated: Aug 8, 2025 Started: Jun 25, 2020 Primary completion: Aug 11, 2023 Completion: Aug 11, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of recruitment

Other terminated trials from National Center for Advancing Translational Sciences (NCATS)

See all terminations from National Center for Advancing Translational Sciences (NCATS)

Other Axial Spondyloarthritis trials with similar outcome

Browse all Axial Spondyloarthritis trials

A PHASE2 clinical study on Axial Spondyloarthritis, this trial is terminated or withdrawn. The trial is conducted by National Center for Advancing Translational Sciences (NCATS) and has accumulated 12 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Nov 2019 – ~Dec 2020 · 13 months · monthly snapshotNot Yet Recruiting~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshotRecruiting~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshotRecruiting~Nov 2021 – ~Apr 2022 · 5 months · monthly snapshotRecruiting~Apr 2022 – ~Nov 2022 · 7 months · monthly snapshotRecruiting~Nov 2022 – ~Jun 2023 · 7 months · monthly snapshotRecruiting~Jun 2023 – ~Jan 2024 · 7 months · monthly snapshotActive Not Recruiting~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshotCompleted~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

12 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE2

  2. Oct 2024 — Sep 2025 [monthly]

    Terminated PHASE2

    Status: Completed → Terminated

  3. Sep 2024 — Oct 2024 [monthly]

    Completed PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  5. Jan 2024 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Active Not Recruiting → Completed

▶ Show 7 earlier versions

  1. Jun 2023 — Jan 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

  2. Nov 2022 — Jun 2023 [monthly]

    Recruiting PHASE2

  3. Apr 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

  4. Nov 2021 — Apr 2022 [monthly]

    Recruiting PHASE2

  5. Jan 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

  6. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  7. Nov 2019 — Dec 2020 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Center for Advancing Translational Sciences (NCATS)
  • The University of Texas Health Science Center, Houston
Data source: The University of Texas Health Science Center, Houston

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations